Fecal occult blood testing in colorectal cancer screening programs

نویسندگان

چکیده

Colorectal carcinoma (CRC) is the third most common cancer worldwide and ranks second as a cause of mortality. CRC screening carried out in many countries for detection early-stage its prevention by removing precancerous lesions, includes fecal occult blood testing colonoscopy. Different use their own approach to screening, including methods blood. The strategy based on fact that already early stages tumor can bleed, small traces stool are detected before onset clinical symptoms disease. testing. Chemical immunochemical used determine feces. chemical method heme peroxidase activity. detects human globin using specific antibodies. be qualitative quantitative. sensitivity quantitative test depends selected threshold stage CRC. lower value, higher sensitivity, but specificity due false positive results. programs different thresholds countries, which caused availability colonoscopy result, well rate this population. To increase test, some suggest it combination with other methods: DNA stool, examination proteins feces (transferrin, haptoglobin). This review presents world testing, advantages limitations; recommendations reporting results test; recommended tests. pilot regions Russian Federation also presented.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Screening for colorectal cancer with fecal occult blood testing.

153 SCREENING FOR COLORECTAL CANCER WITH FECAL OCCULT BLOOD TESTING AND COLONOSCOPY: CORRELATION OF CLINICAL DATA, SITE, SIZE AND DISEASE’S STAGE Iuliana Taraşi, Gabriela Florenţa Dumitrescu, Anca Indrei, P. Plămădeală, Anca Trifan, C. Stanciu, 1 Departament of Gastroenterology, „St. Spiridon” Emergency Clinical Hospital Iaşi 2 Department of Pathology, „Prof. Dr. N. Oblu” Emergency Clinical Hos...

متن کامل

Fecal occult blood testing for colorectal cancer screening.

BACKGROUND Hemoccult II, a widely used guaiac test for fecal occult blood, has a low sensitivity for detecting colorectal neoplasms in asymptomatic patients at average risk. In such patients, the performance characteristics of screening tests developed to improve on Hemoccult II are not known. METHODS A set of three fecal occult-blood tests--Hemoccult II; Hemoccult II Sensa, a more sensitive ...

متن کامل

Fecal occult blood test screening for colorectal cancer.

In summary, high-quality scientific studies indicate that the use of the FOBT for colorectal cancer screening has a number of important advantages. The test is capable of detecting most early colorectal cancers and many advanced adenomas. It has been shown in randomized, controlled trials to reduce substantially colorectal cancer mortality and incidence. The FOBT is feasible, widely available, ...

متن کامل

Population colorectal cancer screening with fecal occult blood test.

Screening for early detection of colorectal cancer using fecal occult blood testing has been shown to be effective in reducing mortality from this disease. The largest Health Maintenance Organization in Israel initiated the use of Hemoccult Sensa in 1992 to evaluate the field performance of this test. All primary care physicians were invited to order home-based tests for their asymptomatic pati...

متن کامل

Immunochemical fecal occult blood tests for colorectal cancer screening.

BACKGROUND The superiority of several immunochemical fecal occult blood tests (I-FOBT) over guaiac-based tests in colorectal cancer screening is now established. The aim of this study was to compare the analytical performance of 3 quantitative I-FOBTs. METHODS Stool samples from 10 healthy volunteers, initially I-FOBT negative, supplemented with human blood, were used to compare reproducibili...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Issledovaniâ i praktika v medicine

سال: 2022

ISSN: ['2409-2231', '2410-1893']

DOI: https://doi.org/10.17709/2410-1893-2022-9-3-11